Changes in interferon-gamma production following specific allergen immunotherapy: biology vs methodology.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 10691883)

Published in Clin Exp Allergy on March 01, 2000

Authors

M Larché

Articles by these authors

Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial. Lancet (2002) 2.38

Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. J Immunol (1997) 1.59

OX40L blockade and allergen-induced airway responses in subjects with mild asthma. Clin Exp Allergy (2014) 1.54

Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions. J Exp Med (1999) 1.48

Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapy. Allergy (2011) 1.20

Induction of interleukin-10 and suppressor of cytokine signalling-3 gene expression following peptide immunotherapy. Clin Exp Allergy (2006) 1.19

Fel d 1-derived T cell peptide therapy induces recruitment of CD4+ CD25+; CD4+ interferon-gamma+ T helper type 1 cells to sites of allergen-induced late-phase skin reactions in cat-allergic subjects. Clin Exp Allergy (2005) 1.12

Allergen-derived T cell peptide-induced late asthmatic reactions precede the induction of antigen-specific hyporesponsiveness in atopic allergic asthmatic subjects. J Immunol (2001) 1.09

Hyper IgM syndrome associated with defective CD40-mediated B cell activation. J Clin Invest (1994) 1.05

The effect of Fel d 1-derived T-cell peptides on upper and lower airway outcome measurements in cat-allergic subjects. Allergy (2005) 1.01

A single strand conformation polymorphism study of CD40 ligand. Efficient mutation analysis and carrier detection for X-linked hyper IgM syndrome. J Clin Invest (1996) 1.00

Elevated expression of the interleukin 4 receptor in carcinoma: a target for immunotherapy? Br J Cancer (1989) 1.00

IL-5 secretion by allergen-stimulated CD4+ T cells in primary culture: relationship to expression of allergic disease. J Allergy Clin Immunol (1997) 0.99

Cat allergen peptide immunotherapy reduces CD4(+) T cell responses to cat allergen but does not alter suppression by CD4(+) CD25(+) T cells: a double-blind placebo-controlled study. Allergy (2004) 0.95

Proliferation and release of IL-5 and IFN-gamma by peripheral blood mononuclear cells from cat-allergic asthmatics and rhinitics, non-cat-allergic asthmatics, and normal controls to peptides derived from Fel d 1 chain 1. J Allergy Clin Immunol (2001) 0.92

Fel d 1-derived synthetic peptide immuno-regulatory epitopes show a long-term treatment effect in cat allergic subjects. Clin Exp Allergy (2015) 0.89

Late asthmatic reactions provoked by intradermal injection of T-cell peptide epitopes are not associated with bronchial mucosal infiltration of eosinophils or T(H)2-type cells or with elevated concentrations of histamine or eicosanoids in bronchoalveolar fluid. J Allergy Clin Immunol (2001) 0.89

Inhibition of alloreactivity by mAb MR6: differential effects on IL-2- and IL-4- producing human T cells. Int Immunol (1994) 0.88

The effects of an anti-CD4 monoclonal antibody, keliximab, on peripheral blood CD4+ T-cells in asthma. Eur Respir J (2001) 0.86

Modelling the human immune response: can mice be trusted? Commentary. Curr Opin Pharmacol (2001) 0.83

Airway expression of calcitonin gene-related peptide in T-cell peptide-induced late asthmatic reactions in atopics. Allergy (2007) 0.83

Analysis of the fine distribution of thymic epithelial microenvironmental molecules by immuno-electron microscopy. Thymus (1989) 0.83

Peptide-mediated immune responses in specific immunotherapy. Int Arch Allergy Immunol (2000) 0.82

Myasthenia gravis thymus: clinical, histological and culture correlations. J Autoimmun (1988) 0.81

Diversity of T-cell receptor alpha gene transcripts in the newborn and adult periphery. Immunogenetics (1992) 0.80

T cell-mediated induction of thymic stromal lymphopoietin in differentiated human primary bronchial epithelial cells. Clin Exp Allergy (2014) 0.80

Of cats and men: immunodominance and the role of HLA-DP/DQ. Clin Exp Allergy (2008) 0.79

Blood eosinophils from atopic donors express messenger RNA for the alpha, beta, and gamma subunits of the high-affinity IgE receptor (Fc epsilon RI) and intracellular, but not cell surface, alpha subunit protein. J Allergy Clin Immunol (2000) 0.79

Indirect recognition of T-cell epitopes derived from the alpha 3 and transmembrane domain of HLA-A2. Am J Transplant (2007) 0.79

Comprehensive metabolomics identifies the alarmin uric acid as a critical signal for the induction of peanut allergy. Allergy (2015) 0.79

Enhanced in vivo immunogenicity induced by an antibody to the IL-4 receptor-associated gp200-MR6 molecule. Scand J Immunol (1996) 0.78

Cytokine responses of peripheral blood mononuclear cells to allergen do not identify asthma or asthma phenotypes. Clin Exp Allergy (2013) 0.77

Allergen isoforms for immunotherapy: diversity, degeneracy and promiscuity. Clin Exp Allergy (1999) 0.76

Fc epsilon RI expression on monocytes in atopic disease: cause or effect? Clin Exp Allergy (1996) 0.75

T-cell responses to house dust mites: bad news for immunotherapy? Clin Exp Allergy (1997) 0.75

T and B cell ontogeny and phylogeny. Curr Opin Immunol (1988) 0.75

Restricted usage of T-cell receptor V alpha sequence and variable-joining pairs after normal T-cell development and bone marrow transplantation. Hum Immunol (1993) 0.75